FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

11429511000001102: Cabergoline 4mg tablets (Teva UK Ltd) 16 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
41063201000001117 Cabergoline 4mg tablets (Teva UK Ltd) 16 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
41063301000001114 Cabergoline 4mg tablets (Teva UK Ltd) 16 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cabergoline 4mg tablets (Teva UK Ltd) 16 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Cabergoline 4mg tablets (Teva UK Ltd) 16 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Cabergoline 4mg tablets (Teva UK Ltd) 16 tablet Is a Cabergoline 4mg tablets 16 tablet true Inferred relationship Existential restriction modifier
Cabergoline 4mg tablets (Teva UK Ltd) 16 tablet Is pack of Cabergoline 4mg tablets (Teva UK Ltd) false Inferred relationship Existential restriction modifier
Cabergoline 4mg tablets (Teva UK Ltd) 16 tablet Has active ingredient Cabergoline false Inferred relationship Existential restriction modifier
Cabergoline 4mg tablets (Teva UK Ltd) 16 tablet Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Cabergoline 4mg tablets (Teva UK Ltd) 16 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Cabergoline 4mg tablets (Teva UK Ltd) 16 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Cabergoline 4mg tablets (Teva UK Ltd) 16 tablet VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Cabergoline 4mg tablets (Teva UK Ltd) 16 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Cabergoline 4mg tablets (Teva UK Ltd) 16 tablet Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Cabergoline 4mg tablets (Teva UK Ltd) 16 tablet Has AMP Cabergoline 4mg tablets (Teva UK Ltd) true Inferred relationship Existential restriction modifier
Cabergoline 4mg tablets (Teva UK Ltd) 16 tablet Has specific active ingredient Cabergoline true Inferred relationship Existential restriction modifier
Cabergoline 4mg tablets (Teva UK Ltd) 16 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Cabergoline 4mg tablets (Teva UK Ltd) 16 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Cabergoline 4mg tablets (Teva UK Ltd) 16 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Cabergoline 4mg tablets (Teva UK Ltd) 16 tablet VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start